According to Bloomage Biotechnology's WeChat account, the QB/T 4576-2023 Industry Standard for sodium hyaluronate, which was revised under the leadership of Bloomage Biotechnology, has officially been implemented. This new standard replaces the previous version, QB/T 4576-2013, and formally includes commercial names such as 'hyaluronic acid' and 'sodium hyaluronate' in the standard document. At the same time, the company has not only revised multiple technical indicators but also promoted its patented technology - high-performance liquid chromatography - as a method for determining the content of sodium hyaluronate. This technology has been included in an industry standard for the first time. The standardization of this technology provides scientific operating norms and a basis for quantifying the content of sodium hyaluronate, which better supports the standardized development of the sodium hyaluronate terminal industry.
华熙生物：主导修订的《透明质酸钠》行业新标准正式实施
Bloomage Biotechnology Corporation Limited: the new industry standard for sodium hyaluronate, which was revised under its leadership, has officially been implemented.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.